Personalized Treatment of Glioblastoma: Current State and Future Perspective

Glioblastoma (GBM) is the most aggressive glial tumor of the central nervous system. Despite intense scientific efforts, patients diagnosed with GBM and treated with the current standard of care have a median survival of only 15 months. Patients are initially treated by a neurosurgeon with the goal...

Descripció completa

Dades bibliogràfiques

Autors principals:	Alen Rončević, Nenad Koruga, Anamarija Soldo Koruga, Robert Rončević, Tatjana Rotim, Tihana Šimundić, Domagoj Kretić, Marija Perić, Tajana Turk, Damir Štimac
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2023-05-01
Col·lecció:	Biomedicines
Matèries:	glioblastoma chemotherapy immunotherapy neurosurgery radiotherapy
Accés en línia:	https://www.mdpi.com/2227-9059/11/6/1579
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!